

Breast cancer, FDA approved, authoritative certification, Pfizer original version Exemestane Aromasin 25mg 30 tablets/box
Indications: 25mg*30 tablets/box is used for the adjuvant treatment of early invasive astrocytic breast cancer in postmenopausal women with positive estrogen receptors after 2-3 years of adjuvant tamoxifen treatment until a total of 5 years of adjuvant endocrine therapy is completed.
Recommended dose: {For reference only, follow the doctor's advice} Adults and elderly patients: The recommended dose is 25 mg, once a day, one tablet each time, and it is recommended to take it after meals. Patients with advanced breast cancer should continue to take this product until tumor progression occurs.


